Table 1.
No. | Age (years) | Sex | Tumor location | Side | Diameter (cm) | Resection | Pathology | Postop therapy | Follow-up timea | Status at the last follow-up |
---|---|---|---|---|---|---|---|---|---|---|
1 | 53 | M | Th + Mid | Left | 3.8 | STR | A | Radio | 25.5 | Death with progression |
2 | 20 | F | Th + Mid | Right | 4.1 | PR | GBM | Radio | 21 | Death with progression |
3 | 20 | M | Th + IC | Right | 4.2 | STR | AA | Radio | 17 | Death with progression |
4 | 33 | M | Th + Mid | Right | 4.1 | GTR | OA | Radio | 24 | Death with progression |
5 | 32 | F | Th | Right | 3.1 | GTR | AA | Radio | 24 | Death with progression |
6 | 47 | F | Th + BG | Left | 3.5 | GTR | GBM | Radio | 30 | Death with progression |
7 | 38 | M | TH + Mid | Right | 3.4 | STR | AA | Radio | 14 | Death with progression |
8 | 37 | M | Th | Left | 3.9 | GTR | A | Radio | 24 | Death with progression |
9 | 56 | M | Th | Left | 1.2 | GTR | A | Radio | 46 | Alive without progression |
10 | 42 | M | Th | Right | 3.2 | GTR | GBM | Radio | 49 | Alive with progression |
11 | 21 | F | Th | Left | 4.5 | STR | AA | Radio | 17 | Death with progression |
12 | 37 | M | Th + IC | Left | 3.5 | GTR | GBM | Radio | 14 | Death with progression |
13 | 29 | M | Th + Mid + IC | Right | 4.1 | GTR | A | Radio | 35 | Death with progression |
14 | 46 | M | Th + IC | Left | 5.3 | GTR | GBM | – | 1 | Death without progression |
15 | 33 | M | Th + IC | Right | 6.2 | PR | GBM | – | – | Lost to follow-up |
16 | 29 | M | Th + IC + PiR | Right | 4.5 | GTR | OAb | Radio + chemo | 25 | Death with progression |
17 | 49 | F | Th | Right | 3.5 | GTR | AA | Radio | 17 | Death with progression |
18 | 48 | M | Th | Left | 4.2 | GTR | AOb | Radio + chemo | 27 | Death with progression |
19 | 36 | M | Th + IC + CTh | Right | 3.2 | PR | AOAb | Radio | 20 | Death without progression |
20 | 24 | M | Th + Mid + IC | Left | 5.4 | GTR | Ab | – | 14 | Alive without progression |
21 | 52 | F | Th + CTh | Right | 2.5 | STR | AOb | Radio + chemo | 2 | Death with progression |
22 | 21 | F | Th + Mid | Right | 3.8 | STR | AOAb | Radio + chemo | 12 | Alive without progression |
23 | 45 | F | Th + Mid | Right | 4.2 | GTR | GBMb | Radio + chemo | 3 | Death without progression |
24 | 30 | M | Th | Right | 3.9 | GTR | GBMb | Radio + chemo | 11 | Alive with progression |
25 | 43 | M | Th | Right | 4.7 | GTR | AAb | Radio + chemo | 11 | Alive without progression |
26 | 63 | F | Th + IC | Left | 4.1 | GTR | OAb | Chemo | 16 | Alive with progression |
27 | 47 | F | Th + BG + IC | Left | 3.4 | PR | GBMb | Radio + chemo | 4 | Alive without progression |
28 | 45 | F | Th + IC | Right | 4.8 | PR | GBMb | – | 3 | Death without progression |
29 | 20 | M | Th + Mid | Right | 5.3 | STR | AAb | Radio + chemo | 21 | Death with progression |
30 | 53 | F | Th + CTh | Left | 5.1 | GTR | OA | – | – | Lost to follow-up |
31 | 31 | M | Th + Mid + IC | Left | 5.2 | STR | AOAb | Radio | 24 | Death with progression |
32 | 66 | M | Th + Mid + IC | Right | 4.5 | GTR | GSM | Chemo | 1 week | Perioperative death |
33 | 48 | M | Th + Mid | Left | 5.2 | STR | GBMb | Radio + chemo | 13 | Death with progression |
Th thalamus, Mid midbrain, IC internal capsule, BG basal ganglia, PiR pineal region, CTh contralateral thalamus, GTR gross total resection (≥90 % resection), STR subtotal resection (≥80 but <90 %), PR partial resection (<80 %), A astrocytoma, AA anaplastic astrocytoma, AO anaplastic oligodendroglioma, AOA anaplastic oligodendroastrocytoma, GBM glioblastoma, GSM gliosarcoma, OA oligoastrocytoma
aThe follow-up time take the month as the unit
bThe molecular pathologies were available